AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$ICCM

IceCure Medical Ltd.

Price · $ICCMvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $ICCM in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $ICCM in the last 30 days.

Top stories · $ICCMMore →
MAY 15·GuruFocusMed

ICCM Maintained by Maxim Group -- Price Target Lowered to $1.00

Maxim Group has maintained a 'Buy' rating for Icecure Medical (ICCM) but significantly lowered its price target to $1.00 from $3.00, reflecting concerns about near-term performance. Despite the analyst's cautious outlook, GuruFocus assesses ICCM as 67.0% undervalued with a GF Value™ of $0.73, while its low GF Score™ of 38/100 highlights potential financial challenges, particularly in profitability. Investors are advised to proceed with caution due to the mixed signals.

MAY 14·www.marketscreener.com

Icecure granted 180-day extension by Nasdaq to regain compliance with minimum bid requirement

IceCure Medical Ltd has received a 180-day extension from Nasdaq to meet the minimum bid price requirement. The company, which specializes in cryoablation systems for tumor treatment, reported its first-quarter earnings for 2026 and other recent company news, including the appointment of a new CFO and positive results from a kidney cancer study. IceCure's main product is the ProSense system, with a multi-probe MultiSense system awaiting commercialization.

News on $ICCM